DD211582A5 - Verfahren zur herstellung von ergopeptinderivaten - Google Patents

Verfahren zur herstellung von ergopeptinderivaten Download PDF

Info

Publication number
DD211582A5
DD211582A5 DD82256213A DD25621382A DD211582A5 DD 211582 A5 DD211582 A5 DD 211582A5 DD 82256213 A DD82256213 A DD 82256213A DD 25621382 A DD25621382 A DD 25621382A DD 211582 A5 DD211582 A5 DD 211582A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
thia
compounds
culture
methylene
Prior art date
Application number
DD82256213A
Other languages
German (de)
English (en)
Inventor
Hans Kobel
Jean-Jacques Sanglier
Hans Tscherter
Georg Bolliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DD211582A5 publication Critical patent/DD211582A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DD82256213A 1981-08-07 1982-08-06 Verfahren zur herstellung von ergopeptinderivaten DD211582A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (1)

Publication Number Publication Date
DD211582A5 true DD211582A5 (de) 1984-07-18

Family

ID=4287999

Family Applications (2)

Application Number Title Priority Date Filing Date
DD82256213A DD211582A5 (de) 1981-08-07 1982-08-06 Verfahren zur herstellung von ergopeptinderivaten
DD82242325A DD206379A5 (de) 1981-08-07 1982-08-06 Verfahren zur herstellung von ergopeptinderivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82242325A DD206379A5 (de) 1981-08-07 1982-08-06 Verfahren zur herstellung von ergopeptinderivaten

Country Status (27)

Country Link
US (3) US4542135A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5843982A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT382156B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU558414B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE894046A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1191802A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH649300A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS235303B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD211582A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3228230A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK352082A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES8402348A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI72979C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2511003B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2109795B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77262B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU190405B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE53647B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL66471A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1152489B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8600311A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8203067A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ201504A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH22998A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75384B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE452011B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA825727B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
RU2131427C1 (ru) * 1992-12-24 1999-06-10 Фармация Энд Апджон С.П.А. Производные эрголина, способ их получения, фармацевтическая композиция
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
CN103827113A (zh) 2011-06-23 2014-05-28 Map药物公司 新型氟麦角碱类似物
US8592445B2 (en) 2011-12-19 2013-11-26 Map Pharmaceuticals, Inc. Iso-ergoline derivatives
SG10201506202RA (en) 2011-12-21 2015-09-29 Map Pharmaceuticals Inc Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ2013590A3 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
CH602765A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-09-27 1978-07-31 Sandoz Ag
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
EP0003286B1 (de) * 1978-01-20 1982-03-24 Sandoz Ag Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
ZA825727B (en) 1984-03-28
FR2511003A1 (fr) 1983-02-11
US4542135A (en) 1985-09-17
HU190405B (en) 1986-09-29
DD206379A5 (de) 1984-01-25
JPS5843982A (ja) 1983-03-14
IL66471A0 (en) 1982-12-31
FI72979C (fi) 1987-08-10
IT8222768A0 (it) 1982-08-06
FR2511003B1 (fr) 1986-12-05
HUT37960A (en) 1986-03-28
AT382156B (de) 1987-01-26
SE8204585D0 (sv) 1982-08-05
DK352082A (da) 1983-02-08
ES514766A0 (es) 1984-01-16
MY8600311A (en) 1986-12-31
ES8402348A1 (es) 1984-01-16
JPH0437836B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-06-22
SE452011B (sv) 1987-11-09
US4804660A (en) 1989-02-14
IL66471A (en) 1986-02-28
CS235303B2 (en) 1985-05-15
ES8504825A1 (es) 1985-04-16
GB2109795A (en) 1983-06-08
IT1152489B (it) 1986-12-31
US4681880A (en) 1987-07-21
FI72979B (fi) 1987-04-30
IE821906L (en) 1983-02-07
CA1191802A (en) 1985-08-13
SE8204585L (sv) 1983-02-08
GR77262B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-11
NL8203067A (nl) 1983-03-01
DE3228230A1 (de) 1983-02-17
FI822670A0 (fi) 1982-07-30
AU558414B2 (en) 1987-01-29
GB2109795B (en) 1985-07-03
CH649300A5 (de) 1985-05-15
AU8678582A (en) 1983-03-03
IE53647B1 (en) 1989-01-04
HU193373B (en) 1987-09-28
PH22998A (en) 1989-02-24
PT75384A (en) 1982-09-01
BE894046A (fr) 1983-02-07
NZ201504A (en) 1986-08-08
ES526119A0 (es) 1985-04-16
ATA302682A (de) 1986-06-15
PT75384B (en) 1985-06-28
FI822670L (fi) 1983-02-08

Similar Documents

Publication Publication Date Title
DD211582A5 (de) Verfahren zur herstellung von ergopeptinderivaten
DE3519834C2 (de) Neue antibiotische Wirkstoffe, Verfahren zu ihrer Gewinnung und ihre Anwendung zur Bekämpfung von Infektionen bei Tieren und Pflanzen
DE69733715T2 (de) Antiparasitäre mittel
DE2040998A1 (de) Neue Antibiotika
DD139520A5 (de) Verfahren zur herstellung eines deoxynarasinkomplexes
DE2514185A1 (de) Halogenierte antibiotika und verfahren zu deren herstellung
DE2028403B2 (de) Pepstatin
DD252116A5 (de) Verfahren zur bekaempfung von pflanzennematoden
DE2209018C2 (de) Glycopeptid-Antibioticum-A-4696-Hydrochlorid und dieses enthaltendes Tierfuttermittel
DE69725287T2 (de) Indolderivate und wurzelbildende mittel, die diese als aktive bestandteile enthalten
DE975919C (de) Verfahren zur Gewinnung eines Mutterkornalkaloidgemisches
DE1617925A1 (de) Pharmazeutisches Praeparat mit antibiotischer Wirkung und Verfahren zu seiner Herstellung
DE68906248T2 (de) Antagonisten fuer den platelet-aktivierungsfaktor, phomactine genannt, ihre herstellung und verwendung.
DE69206858T2 (de) Verbindung UCA1064-B
DE1793766C3 (de) Antibiotikum A 3823
EP0546474A1 (de) Pseurotin F1/F2, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten
EP0546475A1 (de) Biologisch aktives Pseurotin A und D, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten
AT219198B (de) Verfahren zur Gewinnung von neuen antibiotischen Stoffen
FI75188B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 9'-tiaergopeptinderivat.
EP0297523A2 (de) Verfahren zur Herstellung von Elaiophylin und dessen Verwendung
DE2440931C2 (de) Verfahren zur N-Demethylierung von Indolalkaloiden durch Streptomyces albogriseolus
EP1472240B1 (de) Drechsleranol-derivate, verfahren zu deren herstellung und deren verwendung
DE2638400A1 (de) Neue organische verbindung, ihre herstellung und verwendung
DE2621615C3 (de) Dihydromocimycin, seine Salze, Verfahren zu seiner Herstellung und seine Verwendung als Futtermittelzusatz
DE2654266B2 (de) Verfahren zur mikrobiologischen Herstellung von 5,10,11,1 la-Tetrahydro-9,1 ldihydroxy-8-methyl-5oxo-lH-pyrrolo [2,1-c] [1,4] benzodiazepin-2acrylamid